Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer-Reference-Cited by-同舟云学术

Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer

Published:2017-04-03 Issue:5 Volume:35 Page:333-344
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Bhavsar Nrupen A.¹,Harrison Michael R.¹,Hirsch Bradford R.¹,Creel Patricia¹,Wolf Steve P.¹,Samsa Greg P.¹,Abernethy Amy P.¹²,Simantov Ronit²,Borham Azah²,George Daniel J.¹

Affiliation:

1. Duke University Medical Center, Durham, North Carolina, USA

2. Pfizer Inc., New York, New York, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2017.1289215

Reference23 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.

2. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

3. A New Initiative on Precision Medicine

4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Kidney Cancer Version 2. 2017–October 31, 2016. Available from: http://www.nccn.org. [Accessed 2016 Nov. 16]

5. “Real World” Treatment of Metastatic Renal Cell Carcinoma in a Joint Community-Academic Cohort: Progression-Free Survival Over Three Lines of Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Rationale of the Outcomes Database to Prospectively Assess the Changing Therapy Landscape in Renal Cell Carcinoma Registry: A Multi-institutional, Prospective Study of Patients with Metastatic Renal Cell Carcinoma;European Urology Open Science;2024-08

2. A rapid review of patient-reported outcomes investigated in the context of advanced renal cell cancer or advanced hepatocellular cancer;European Journal of Oncology Nursing;2023-04

3. A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience;Clinical Genitourinary Cancer;2022-02

4. Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC);Cancer;2021-03-25

5. Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival;Kidney Cancer;2019-08-07